ADJUVANT THERAPY IN LYMPH-NODE POSITIVE P ROSTATE-CANCER

Few patients with prostate cancer metastatic to the lymphnodes can be cured by radiotherapy, radical prostataectomy or androgen deprivation. Inevitably serum PSA levels will rise after a few years whereas the c linical recurrence appears after 5 to 10 years. Prospective trials reg arding adjuvant treatment of lymphnode positive prostate cancer do not exist. Retrospective studies involving adjuvant endocrine treatment r eveal a prolonged disease free survival time. Scientific proof of the best treatment for prostate cancer with lymphnode metastasis does not exist. The decision how to treat is based on our personal experience a nd philosophy as well as on our knowledge and interpretation of the av ailable lierature. The art of medicine is the feeling for the best tre atment of each individual patient.